IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?. Mediterr J Hematol Infect Dis [Internet]. 2019 Oct. 30 [cited 2026 Jun. 13];11(1):e2019063. Available from: https://www.mjhid.org/mjhid/article/view/2019.063